The prevalence of allergic diseases has risen in recent decades 1, with up to 300 million people worldwide now estimated to suffer from asthma. Although susceptibility for these conditions has a ...

The seasonal allergic phenotype is characterized by being limited to seasons that correspond to allergen-specific IgE released in response to seasonal inhalant allergens. Severity of Asthma ...

Phenotype of dendritic cells (DCs ... recognized by DCs to favor Th1 or Tregs, can ameliorate allergic asthma.

Symptom medication neither alters the tendency of allergies to develop into polyallergies nor inhibits the increased severity of disease phenotype—such as from hay fever to asthma. The third ...

Depemokimab, an ultra-long-acting biologic agent with enhanced binding affinity for interleukin-5, may improve outcomes in patients with asthma with an eosinophilic phenotype. New research ...